Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Alexander Wunderink is active.

Publication


Featured researches published by Alexander Wunderink.


Acta Psychiatrica Scandinavica | 2006

Treatment delay and response rate in first episode psychosis.

Alexander Wunderink; Fokko Nienhuis; Sjoerd Sytema; Durk Wiersma

Objective:  There is no consistent evidence of long duration of untreated psychosis (DUP) predicting long time to response (TTR) in first psychosis. This study aims to investigate the predictors of DUP and TTR in a first episode patient population.


Schizophrenia Research | 2008

RECOVERY AND ITS RELATION TO SYMPTOMATIC AND FUNCTIONAL REMISSION IN FIRST EPISODE PSYCHOSIS

Alexander Wunderink; Sjoerd Sytema; Fokko Nienhuis; Durk Wiersma

Introduction: Generally agreed outcome criteria in psychosis are required to evaluate the effectiveness of new treatment strategies and surmount therapeutic pessimism. The aim of this study is to explore recovery and its relation to symptomatic and functional remission in first episode patients and to find predictors of recovery. Methods: In a sample of first episode patients (N = 125) symptomatic and functional remission during the last nine months of a two years follow-up period were examined, as well as recovery and its predictors. Recovery was clinically defined by the two dimensions of symptomatic and functional remission. Results: Half the patients (52.0%) showed symptomatic remission, a quarter (26.4%) showed functional remission, while one fifth (19.2%) met both criteria-sets and were considered recovered. Functionally remitted patients recovered in 72.7% (OR = 2.7), symptomatically remitted patients in 36.9% (OR = 0.6). Recovery was significantly associated with short duration of untreated psychosis (OR = 0.531, df = 1, p = 0.008). No recovery occurred in patients with long duration of untreated psychosis (>6 months). Another significant predictor of recovery was better baseline functioning (OR = 0.858, df = 1, p = 0.021). Conclusions: Functional remission is more selectively associated with recovery than symptomatic remission. Treatment delay reduces chance of recovery. Baseline functioning levels also significantly predict recovery. Our results clearly show that social functioning is an important parameter in schizophrenia outcome research, both as a predictor of future course characteristics, and as a more selective index of recovery than symptom remission. References [1] Andreasen NC, Carpenter WT, Jr., Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 2005 Mar;162(3):441-9


Schizophrenia Bulletin | 2007

Feasibility of targeted and maintenance treatment in remitted first episode psychosis

Fokko Nienhuis; Alexander Wunderink; Durk Wiersma


Schizophrenia Research | 2006

GUIDED DISCONTINUATION VERSUS MAINTENANCE TREATMENT IN REMITTED FIRST EPISODE PSYCHOSIS: RELAPSE RATES AND FUNCTIONAL OUTCOME

Alexander Wunderink; Fokko Nienhuis; Sjoerd Sytema; Durk Wiersma


European Psychiatry | 2007

The MESIFOS-trial: Treatment strategies in remitted first episode psychosis

Durk Wiersma; Alexander Wunderink; Fokko Nienhuis; Sjoerd Sytema


Schizophrenia Research | 2006

Feasibility of carrying out targeted and maintenance treatment in first episode psychosis

Fokko Nienhuis; Alexander Wunderink; Durk Wiersma


Schizophrenia Research | 2006

Targeted treatment revisited: Results of an RCT in first episode psychosis

Alexander Wunderink; Fokko Nienhuis; Sjoerd Sytema; Cj Slooff; Durk Wiersma


Schizophrenia Research | 2003

Mesifos : Medication strategies in first onset schizophrenia effects of short versus sustained antipsychotic treatment on quality of life after first episode psychosis: A randomized trial

Fokko Nienhuis; Alexander Wunderink; Durk Wiersma; Rj van den Bosch; Richard Bruggeman; G Faber; J van der Linde; E Noorthoorn; Cees J. Slooff; P Vlaminck; D van der Werf; P de Wit


Early Intervention in Psychiatry | 2012

Measuring functional remission: A tool for clinical practice and preliminary data on symptomatic and functional remission and recovery

Alexander Wunderink; Philippe Delespaul; Mark van der Gaag; Lieuwe de Haan; Don Linszen; Niels Mulder; Jim van Os; Wim Veling; Jaap van Weeghel; Durk Wiersma


Schizophrenia Bulletin | 2011

6-YEAR FOLLOW UP OF THE MESIFOS INCIDENCE COHORT

Fokko Nienhuis; Roeline Nieboer; Alexander Wunderink; Durk Wiersma

Collaboration


Dive into the Alexander Wunderink's collaboration.

Top Co-Authors

Avatar

Durk Wiersma

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar

Fokko Nienhuis

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar

Sjoerd Sytema

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar

Cj Slooff

University of Groningen

View shared research outputs
Top Co-Authors

Avatar

Richard Bruggeman

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar

A. Al Hadity

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bob Wilffert

University of Groningen

View shared research outputs
Top Co-Authors

Avatar

Cees J. Slooff

University Medical Center Groningen

View shared research outputs
Top Co-Authors

Avatar

Don Linszen

University of Amsterdam

View shared research outputs
Researchain Logo
Decentralizing Knowledge